On Episode 12 of the Ori Spotlight Podcast Jason C. Foster sits down with Northpond Ventures, investor in both Ori’s Series A and Series B funding. We caught up with Directors Adam Wieschhaus and Shaan Gandhi, as they share their insights into the cell and gene therapy space. Northpond Ventures is a venture capitalist firm focused on life science, medicine, and technology; with 60 investments to date since its inception. Adam and Shaan lead their San Francisco and Boston offices respectively. Adam and Shaan sit down with Jason to discuss why bringing scalable cell and gene therapies to market is vital, the impact these therapies have on patients, and what excites them most about the investments made within the CGT space.